Early Trial Finds Dexmedetomidine Cuts Delirium in Critically Ill Early Trial Finds Dexmedetomidine Cuts Delirium in Critically Ill

Low-dose nocturnal dexmedetomidine can reduce the risk of delirium in critically ill patients, according to a new phase 2 trial.Reuters Health Information

Source: Medscape Critical Care Headlines - March 8, 2018 Category: Intensive Care Tags: Critical Care News Source Type: news